Home of Hepatology7 rue Daubin1203 GenevaSwitzerland+41 22 807 03 60easloffice@easloffice.eu© 2025 EASL. All rights reserved.Website by Soto.Privacy Policy | Cookie Policy | Terms & Conditions | Cyber Security Explore offerUnlock the full potential of being part of the EASLcommunity. As a member, you’ll gain access toexclusive resources, reduced event fees, top-tierjournals, and professional development opportunitiesdesigned to support your career in hepatologyBecome a memberNurses & Allied Health ProfessionalsLink titleYoung InvestigatorsLink titleBasic ScienceLink titleTitle here Lorem ipsum At the heart of EASL is a diverse and dynamic international community of professionals dedicated to advancing hepatology.Discover how you can get involved and make an impact.Whether you're a member, a Young Investigator, a nurse or allied health professional, or focused on basic science, there's a place for you here. Explore the different pathways to connect, grow and contribute, from membership benefits to tailored programmes and scientific networksLorem ipsum dolor sit ipsum CommunitySign In / Sign UpResourcesWhat We DoAbout Us Partnerships

José Willemse

José Willemse served as the executive director of the Dutch Liver Patients Association, board member of Liver Patients International, umbrella organization for liver patient organisations, member of the management board of the European Reference Network Rare-Liver. Besides this, she is a member of several NAFLD/NASH related platforms

She has been active in the (international) field of NAFLD/NASH since 2014. One of the highlights is being one of the co-authors of the EASL guideline NAFLD from a patient perspective.

Besides her involvement in the world of NAFLD/NASH, she has 25 years of experience with the patient perspective in healthcare. She knows what a disease means to a patient, how it affects their live and how stigma can affect their wellbeing. Without realising, a name of a disorder can play an essential role here as well.

Scroll to Top